More Saudi-French Investments Expected in Renewable Energy

Saudi and French officials meet to discuss bolstering energy relations. (SPA)
Saudi and French officials meet to discuss bolstering energy relations. (SPA)
TT

More Saudi-French Investments Expected in Renewable Energy

Saudi and French officials meet to discuss bolstering energy relations. (SPA)
Saudi and French officials meet to discuss bolstering energy relations. (SPA)

Business experts expected Saudi-French investments in renewable energy to increase in light of the joint statement issued by Saudi Minister of Energy Prince Abdulaziz bin Salman bin Abdulaziz and French Minister of Energy Transition Agnes Pannier-Runacher that underlined efforts to enhance energy efficiency and cooperation in peaceful nuclear power.

Dr. Mohamed Ben Laden, president of the Saudi-French Business Council, told Asharq Al-Awsat that the volume of trade exchange between the two countries was expected to increase, in view of the alignment of Saudi Vision 2030 and France 2030 strategy, in terms of hydrogen and the reduction of carbon emissions.

Ben Laden noted that the strategic partnership included cooperation in mega structural projects worth billions of euros, stressing that the council would continue to assume its role in attracting more French investments to the Saudi market by promoting the incentives offered by the Kingdom and all available opportunities.

Eng. Majid Refae, Chairman of the Board of Directors of the Saudi Polytechnic Institute for Renewable Energy and CEO of Desert Technologies for Industry, told Asharq Al-Awsat that the two countries have developed relations in the field of energy, represented in many projects in oil refining, petrochemical production, electricity and renewable energy.

Refae highlighted the increase in the number of French companies investing in the Kingdom from 259 in 2019 to 336 last year. He added that Saudi Arabia and France have worked to strengthen bilateral investment relations and build long-term partnerships between their private sectors.

He underscored the presence of many Saudi-French joint projects, including SATORP, one of the world’s most efficient integrated refining and petrochemicals platforms – an alliance between Saudi Aramco and Total Energies.

“The visit of the Saudi Crown Prince to France and his participation in the Summit for a New Global Financing Pact reflected the depth of these relations and the Kingdom’s leading role, position and global influence,” Refae said.

He also stressed the two countries’ aspiration to benefit from the opportunities offered by the Kingdom’s vision and the economic plan of France 2030 to develop and strengthen economic partnership in the areas of mutual investment, especially in the field of energy.

According to the joint Saudi-French statement, the two parties agreed to make efforts to enhance energy efficiency and cooperation in the field of nuclear energy, within a peaceful and safe framework, manage radioactive waste and nuclear applications, and develop human capabilities.

They acknowledged the importance of advancing the implementation of the United Nations Framework on Climate Change (UNFCCC) and the Paris Agreement.

“Addressing climate change and promoting secure, reliable, affordable and sustainable supplies of energy are shared strategic priorities of Saudi Arabia and France,” the statement read.

It added: “Moreover, the two countries recognize that clean hydrogen is an essential fuel to reach the shared objective of promoting a sustainable economic development while mitigating the impact of climate change.”



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.